Clinical Trial Update: Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker

View source ↗

Summary

The clinical trial evaluating a maternal plasma marker for noninvasive fetal aneuploidy screening has completed, with focus on detecting Down syndrome and Edwar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Down Syndrome
• Edwards Syndrome

Snippet

Sponsor: Sequenom, Inc. | Conditions: Pregnancy, Aneuploidy | Status: COMPLETED